Clinical TrialsSearch results
Number of results: 253
Other
- Candesartan Antihypertensive Survival Evaluation in Japan (CASE-J) Trial of Cardiovascular Events in High-Risk Hypertensive Patients
- Hypertension
- EBM Collaborating Research Center in Kyoto University
- 2005-10-30
Other
- Assessment of clinical usefulness in CKD patients with atorvastatin trial (ASUCA Trial)
- Hyperlipidemia with Chronic Kidney Disease (CKD)
- Kyoto University Graduate School of Medicine
- 2009-03-17
Other
- The high-risk strategy by lifestyle modification (HISLIM) study
- hypercholesterolemia,hypertension,smoking
- HISLIM study research group
- 2005-10-01
Other
- LIVES Study Extention
- hypercholesterolemia
- LIVES Study Extension advisory committee
- 2007-09-18
Other
- Randomized Study to Assess the Efficacy of a Further 5 Years of Anastrozole Treatment for Postmenopausal Women with Breast Cancer Completing 5 Years Anastrozole Containing Adjuvant Endocrine Therapy
- Hormone-responsive postmenopausal primary breast cancer
- AERAS executive committee
- 2007-09-05
Other
- Phase III Randomized Adjuvant Study of Tamoxifen Alone Versus Sequential Tamoxifen and Anastrozole in Hormone-Responsive Postmenopausal Breast Cancer Patients
- Hormone-responsive postmenopausal primary breast cancer
- N-SAS BC 03 executive committee
- 2005-08-12
Other
- Phase II study of caffeine combined chemotherapy in patients with high- grade bone and soft tissue tumor
- High-grade bone and soft tissue tumor
- Group for "Caffeine combined chemotherapy in patients with high-grade bone and soft tissue tumor"
- 2008-03-25
Other
- Phase 2 study of G-CSF priming chemotherapy for high risk myelodysplastic syndrome (MDS) and MDS/secondary AML
- High risk myelodysplastic syndrome and MDS/secondary AML
- Japan Adult Leukemia Study Group
- 2006-04-17
Other
- Cohort study to investigate the clinical factors associated with the prognosis of high risk myelodysplastic syndrome (MDS) and MDS/secondary AML
- High risk myelodysplastic syndrome and MDS/secondary AML
- Japan Adult Leukemia Study Group
- 2006-04-17
Other
- JBCRG-M06(EMERALD)
- HER2-positive progressive-recurrent breast cancer
- Yamashita Toshinari
- 2019-03-25